<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03608293</url>
  </required_header>
  <id_info>
    <org_study_id>RC-P0014</org_study_id>
    <nct_id>NCT03608293</nct_id>
  </id_info>
  <brief_title>Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells</brief_title>
  <acronym>Aerotox-1</acronym>
  <official_title>Particulate Air Pollution : Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lille Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université du Littoral Côte d'Opale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lille Catholic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cigarette smoking is a habit that has spread all over the world and is a significant risk&#xD;
      factor for many diseases including cardiovascular disease, chronic obstructive pulmonary&#xD;
      disease(COPD),asthma and lung cancer.&#xD;
&#xD;
      Evaluation and understanding of tobacco health effects are of major interest worldwide and&#xD;
      answer to important societal concerns.&#xD;
&#xD;
      Identification of new biomarkers of exposure to tobacco smoke potentially implicated in COPD&#xD;
      or lung carcinogenesis would allow a better observation of tobacco exposed population, thanks&#xD;
      to screening establishment at reversible stages of pathological processes.&#xD;
&#xD;
      In this study, we question whether cigarettes smoking alters miRNA profiles of extracellular&#xD;
      vesicles (EVs) present in human broncho alveolar lavages (BALs), which could affect&#xD;
      surrounding normal bronchial epithelial cells status.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extracellular vesicles (EVs) include a variety of nanoscale membranous vesicles (exosomes,&#xD;
      microvesicles, microparticles). EVs are released into the interstitial fluid from a wide&#xD;
      variety of normal or diseased cells.&#xD;
&#xD;
      Analysis of EVs and their content maybe useful as disease biomarkers as they reflect the&#xD;
      contents of cells of origin, differ between normal and diseased tissue and can be reliably&#xD;
      detected.&#xD;
&#xD;
      EVs may thus act as biomarkers of diverse pathologies like cancer, and detection of these&#xD;
      biomarkers maybe applied to early diagnosis or assessment of prognosis in patients with&#xD;
      cancer. EVs indeed contain both mRNAs and non-coding RNAs, such as small regulatory microRNAs&#xD;
      (miRNAs).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2012</start_date>
  <completion_date type="Actual">December 31, 2013</completion_date>
  <primary_completion_date type="Actual">July 31, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of target mRNA expression in human bronchial epithelial cells (BEAS-2 B) exposed to EVs isolated from LBA of patients</measure>
    <time_frame>Through the study completion, an average of 48 months</time_frame>
    <description>Quantitative polymerase chain reaction (RT-qPCR) for determination of mRNA expression</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Smokers</condition>
  <condition>Human Bronchial Epithelial Cells</condition>
  <condition>Lung Pathogenesis</condition>
  <condition>Biomarkers</condition>
  <arm_group>
    <arm_group_label>Smokers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Smokers outpatients at the Pneumology service from the HôpitalSaint-Philibert (Lomme, France) to whom a bronchoalveolar lavage will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non smokers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non smokers outpatients at the Pneumology service from the HôpitalSaint-Philibert (Lomme, France) to whom a bronchoalveolar lavage will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Broncho Alveolar Lavages (BAL)</intervention_name>
    <description>BEAS-2 B cells are exposed to EVs isolated from BAL of smokers and non-smokers.</description>
    <arm_group_label>Non smokers</arm_group_label>
    <arm_group_label>Smokers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;18 year-old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of informed consent&#xD;
&#xD;
          -  Drug treatment&#xD;
&#xD;
          -  Professional exposure&#xD;
&#xD;
          -  Evolutive pregnancy&#xD;
&#xD;
          -  Bradycardia&#xD;
&#xD;
          -  Respiratory assistance required,&#xD;
&#xD;
          -  Diagnosed respiratory distress (e.g. COPD, asthma)&#xD;
&#xD;
          -  Infectious pneumopathy&#xD;
&#xD;
          -  Bronchial cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Gosset, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GHICL</affiliation>
  </overall_official>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <last_update_submitted>July 24, 2018</last_update_submitted>
  <last_update_submitted_qc>July 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

